Stefan Marcel Herman Leurs

Title: Innovations of Stefan Marcel Herman Leurs

Introduction

Stefan Marcel Herman Leurs is a notable inventor based in Vosselaar, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative processes for producing various chemical compounds. With a total of 3 patents to his name, Leurs continues to impact the industry with his inventive solutions.

Latest Patents

One of Leurs' latest patents is a process for the production of n-(2,6-dimethyl-phenyl)-2-piperazin-1-yl-acetamide, commonly known as N-lidocaine. This novel process is designed for industrial exploitation and involves the reaction of piperazine with N-haloacetyl-2,6-xylidine. The process includes several consecutive steps, making it efficient for large-scale production.

Another significant patent by Leurs is for the production of [2-(4-fluoro-benzyl)-phenyl]-acetic acid. This compound can be obtained from phthalic anhydride and involves a series of steps that enhance its production efficiency. The resulting [2-(4-fluoro-benzyl)-phenyl]-acetic acid is characterized by its high purity, exceeding 95%, and is suitable for industrial-scale reactors.

Career Highlights

Stefan Leurs is currently associated with Janssen Pharmaceutica NV, a leading pharmaceutical company. His work there has allowed him to focus on innovative processes that contribute to the development of new medications and treatments. His expertise in chemical processes has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Leurs has collaborated with several notable colleagues, including Michel Joseph Maurice André Guillaume and Dirk De Smaele. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Stefan Marcel Herman Leurs is a distinguished inventor whose work in pharmaceutical processes has led to significant advancements in the industry. His innovative patents and collaborations highlight his commitment to improving chemical production methods. Through his contributions, Leurs continues to shape the future of pharmaceuticals.